LongRiver Investments held its 2026 Annual Conference in Shanghai on September 2, 2026. The event brought together around 140 participants, including representatives from global insurers and asset managers, industry leaders, founders and ecosystem partners, to exchange perspectives on healthcare, frontier technologies, capital markets and global growth opportunities.
LongRiver Investments held its 2026 Annual Conference in Shanghai on September 2, 2026. The event brought together around 140 participants, including representatives from global insurers and asset managers, industry leaders, founders and ecosystem partners, to exchange perspectives on healthcare, frontier technologies, capital markets and global growth opportunities.
Yuan Siong Lee, Group Chief Executive and President, AIA Group, and Dr. Mark Konyn, Group Chief Investment Officer, AIA Group, delivered opening remarks. Jiang Zhang, Founder & CEO, LongRiver Investments, gave a keynote presentation.
Wei Xu, Professor and Vice Dean, Institute for Interdisciplinary Information Sciences, Tsinghua University, and Jacqueline Jiang, Vice President of Global Issuer Services, HKEX, explored opportunities in AI agent applications and Hong Kong's capital markets, respectively.
Wenxin Yu, Deputy Head of Research Institute & Chief Analyst for Pharmaceutical Industry, Guotai Haitong Securities; Dr. Dou Shen, Executive Vice President, Baidu Group and President, Baidu Intelligent Cloud Business Group; and Victor Yang, CEO, ChinaVenture Investment Consulting, shared perspectives on healthcare, enterprise adoption of AI agents and the venture capital market.
Representatives from Redomain Therapeutics, Axoft, Metix AI and Romangic presented advances in nucleic acid delivery, brain–computer interfaces, AI recruitment and image creation. An on-site innovation exhibition also showcased technologies and practical applications from companies and partners across LongRiver's network.
Three panel discussions brought together participants from industry, insurance and investment institutions to explore developments and opportunities in healthcare innovation, technology applications and capital allocation.
